245 related articles for article (PubMed ID: 27761236)
1. Utility of susceptibility-weighted imaging in Parkinson's disease and atypical Parkinsonian disorders.
Wang Z; Luo XG; Gao C
Transl Neurodegener; 2016; 5():17. PubMed ID: 27761236
[TBL] [Abstract][Full Text] [Related]
2. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
[TBL] [Abstract][Full Text] [Related]
3. Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders.
Zhang P; Chen J; Cai T; He C; Li Y; Li X; Chen Z; Wang L; Zhang Y
Front Aging Neurosci; 2022; 14():909552. PubMed ID: 35992605
[TBL] [Abstract][Full Text] [Related]
4. Iron deposition in subcortical nuclei of Parkinson's disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies.
Jin J; Su D; Zhang J; Lam JST; Zhou J; Feng T
Chin Med J (Engl); 2024 May; ():. PubMed ID: 38809051
[TBL] [Abstract][Full Text] [Related]
5. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
Sjöström H; Granberg T; Westman E; Svenningsson P
Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
[TBL] [Abstract][Full Text] [Related]
6. Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.
Fedeli MP; Contarino VE; Siggillino S; Samoylova N; Calloni S; Melazzini L; Conte G; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
Eur J Radiol; 2020 Dec; 133():109394. PubMed ID: 33190103
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease and Parkinsonism syndromes: Evaluating iron deposition in the putamen using magnetic susceptibility MRI techniques - A systematic review and literature analysis.
Mohammadi S; Ghaderi S
Heliyon; 2024 Apr; 10(7):e27950. PubMed ID: 38689949
[TBL] [Abstract][Full Text] [Related]
8. Quantitative susceptibility mapping in atypical Parkinsonisms.
Mazzucchi S; Frosini D; Costagli M; Del Prete E; Donatelli G; Cecchi P; Migaleddu G; Bonuccelli U; Ceravolo R; Cosottini M
Neuroimage Clin; 2019; 24():101999. PubMed ID: 31539801
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.
Lee JH; Han YH; Kang BM; Mun CW; Lee SJ; Baik SK
J Neurol; 2013 Aug; 260(8):2094-101. PubMed ID: 23670309
[TBL] [Abstract][Full Text] [Related]
10. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study.
Zhang J; Zhang Y; Wang J; Cai P; Luo C; Qian Z; Dai Y; Feng H
Brain Res; 2010 May; 1330():124-30. PubMed ID: 20303339
[TBL] [Abstract][Full Text] [Related]
11. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
[TBL] [Abstract][Full Text] [Related]
12. The role of iron in Parkinson's disease monkeys assessed by susceptibility weighted imaging and inductively coupled plasma mass spectrometry.
Li SJ; Ren YD; Li J; Cao B; Ma C; Qin SS; Li XR
Life Sci; 2020 Jan; 240():117091. PubMed ID: 31760102
[TBL] [Abstract][Full Text] [Related]
13. Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism.
Sjöström H; Surova Y; Nilsson M; Granberg T; Westman E; van Westen D; Svenningsson P; Hansson O
Sci Rep; 2019 Apr; 9(1):6079. PubMed ID: 30988382
[TBL] [Abstract][Full Text] [Related]
14. Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism.
Gupta D; Saini J; Kesavadas C; Sarma PS; Kishore A
Neuroradiology; 2010 Dec; 52(12):1087-94. PubMed ID: 20358367
[TBL] [Abstract][Full Text] [Related]
15. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
[TBL] [Abstract][Full Text] [Related]
16. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
[TBL] [Abstract][Full Text] [Related]
17. MRI-Based Radiomics of Basal Nuclei in Differentiating Idiopathic Parkinson's Disease From Parkinsonian Variants of Multiple System Atrophy: A Susceptibility-Weighted Imaging Study.
Pang H; Yu Z; Li R; Yang H; Fan G
Front Aging Neurosci; 2020; 12():587250. PubMed ID: 33281598
[TBL] [Abstract][Full Text] [Related]
18. Multi-parametric radiomics of conventional T1 weighted and susceptibility-weighted imaging for differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy.
Bu S; Pang H; Li X; Zhao M; Wang J; Liu Y; Yu H
BMC Med Imaging; 2023 Dec; 23(1):204. PubMed ID: 38066432
[TBL] [Abstract][Full Text] [Related]
19. Automated volumetric determination of high R
Tessema AW; Lee H; Gong Y; Cho H; Adem HM; Lyu I; Lee JH; Cho H
NMR Biomed; 2022 Nov; 35(11):e4795. PubMed ID: 35775868
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI.
Wu SF; Zhu ZF; Kong Y; Zhang HP; Zhou GQ; Jiang QT; Meng XP
Eur Rev Med Pharmacol Sci; 2014; 18(18):2605-8. PubMed ID: 25317792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
